BlueCrest Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12	Closed	-$194K	–	442
2019 Q1	$194K	Buy	12 +2	+20%	+$32.3K	0.01%	953
2018 Q4	$93K	Buy	+10	New	+$93K	﹤0.01%	761